Starling Oncology, Inc. Operating Lease, Liability, Noncurrent
Starling Oncology, Inc. (STLN) had Operating Lease, Liability, Noncurrent of $17.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $17.38M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $18.84M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $19.13M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $20.20M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $17.38M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $18.84M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $19.13M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $20.20M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $21.18M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $21.60M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $23.22M 10-K · filed 2026-03-12 |
| 2024-09-30 | $24.66M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $24.54M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $25.06M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $26.49M 10-K · filed 2025-03-26 |
| 2023-09-30 | $26.01M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $26.65M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $22.25M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $22.06M 10-K · filed 2024-03-28 |
| 2022-09-30 | $21.83M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $14.61M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.41M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |